Advertisement

Topics

Drug Facts | COMMIT

04:28 EDT 27th August 2014 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Nicotine polacrilex, 4 mg

Nicotine polacrilex, 2 mg

Stop smoking aid

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.

aspartame, calcium polycarbophil, flavor, magnesium stearate, mannitol, potassium bicarbonate, sodium alginate, sodium carbonate, xanthan gum

call toll-free 1-888-569-1743 (English/Spanish) weekdays (9:00 am – 4:30 pm ET)

30490IB

Distributed by:

GlaxoSmithKline Consumer Healthcare, L.P.

Moon Township, PA 15108, Made in the U.K.

©2008 GlaxoSmithKline

Commit

Nicotine polacrilex lozenge, 4mg

STOP SMOKING AID

108 LOZENGES

4mg EACH

FROM THE MARKETERS OF NICORETTE

Includes User’s Guide

ORIGINAL FLAVOR

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP.

If you smoke your first cigarette MORE THAN 30 MINUTES after waking up, use Commit 2mg Lozenge

This product is protected in sealed blisters.

Do not use if individual blisters or printed backings are broken, open or torn.

COMMIT®, COMMITTED QUITTERS®, NICORETTE®, and associated logo designs and overall trade dress designs are trademarks owned and/or licensed to GlaxoSmithKline or its affiliated companies.

TO INCREASE YOUR SUCCESS IN QUITTING:

go to www.commitlozenge.com for online support program

Commit

Nicotine polacrilex lozenge, 2mg

STOP SMOKING AID

108 LOZENGES

2mg EACH

FROM THE MARKETERS OF NICORETTE

Includes User’s Guide

ORIGINAL FLAVOR

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP.

If you smoke your first cigarette WITHIN 30 MINUTES of waking up, use Commit 4mg Lozenge

This product is protected in sealed blisters.

Do not use if individual blisters or printed backings are broken, open or torn.

COMMIT®, COMMITTED QUITTERS®, NICORETTE®, and associated logo designs and overall trade dress designs are trademarks owned and/or licensed to GlaxoSmithKline or its affiliated companies.

TO INCREASE YOUR SUCCESS IN QUITTING:

go to www.commitlozenge.com for online support program

Manufacturer

GlaxoSmithKline Consumer Healthcare LP

Active Ingredients

Source

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Commit [GlaxoSmithKline Consumer Healthcare LP]

Drug Facts

Nicorette [GlaxoSmithKline Consumer Healthcare LP]

Drug Facts

Members mark nicotine [Sam's West Inc]

Sam's West, Inc. Nicotine Lozenge Drug Facts

Good sense nicotine [L Perrigo Company]

Perrigo Nicotine Lozenge Drug Facts

In control nicotine [H E B]

HEB Nicotine Polacrilex Lozenge 2 mg (Nicotine) Drug Facts

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Contemporary Modalities in Treatment of Heart Failure

The Contemporary Modalities In Treatment of Heart Failure Registry (COMMIT-HF) is an observational study on an all-comer systolic heart failure population hospitalized in a highly speciali...

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

The study is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control in patients using a modern insulin: NovoRapid®, NovoMix® 30 or Levemir® fo...

A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.

The COMMIT Study will assess the safety and effectiveness of FLX-787 in men and women with Charcot-Marie-Tooth disease (CMT) experiencing muscle cramps. Participants will be asked to take ...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria to Commit Suicide with a Gram-Positive Antibiotic.

Many antibiotics lack activity against Gram-negative bacteria because they cannot permeate the outer membrane or suffer from efflux and, in the case of β-lactams, are degraded by β-lactamases. Herei...

Yeast Cells Exposed to Exogenous Palmitoleic Acid Either Adapt to Stress and Survive or Commit to Regulated Liponecrosis and Die.

A disturbed homeostasis of cellular lipids and the resulting lipotoxicity are considered to be key contributors to many human pathologies, including obesity, metabolic syndrome, type 2 diabetes, cardi...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record